Fundamental Data for PCOP

Pharmacopeia is a chemistry-based collaborative drug discovery company, focused on the creation of new small molecule therapeutics. Using proprietary technologies and processes, PDD''s experienced scientists identify and optimize novel drug candidates through research collaborations with major pharmaceutical and biological companies and through its own internally-funded drug discovery programs.

# Employees: 169

Address: P.O. Box 5350,Princeton,NJ,USA

Phone: 609-452-3600

Fax: 609-452-3672

Website: www.pharmacopeia.com

Email: ir_pr@pcop.com

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Joseph A Mollica Ph.D. (Chmn.)

Leslie J. Browne Ph.D. (Presi.; C.E.O.; Dir.)

Michio Soga (Exec. V.P.; C.F.O.)

Brian M. Posner (V.P.; Chief Acctg. Off.)

Carol A. Ammon (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2008

Next Earnings Date(Expected): 2/19/2009

Mean EPS (Next Qtr): ($0.32)

Mean EPS (Year): ($1.63)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 2

Shares Performance

Period	PCOP	Compare to S&P
YTD	-64.57 %	-40.71 %
4 Weeks	87.78 %	83.51 %
12 Weeks	13.42 %	43.97 %

Shares Information

Analyst Coverage: Y

Avg Volume: 252568

Shares Outstanding: 29M

Market Cap: $0.05B

52 Week High: $5.46

52 Week Low: $0.73

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 PCOP split by factor of 1.500

Earnings Performance

EPS Growth in Last Quarter: 40.82 %

EPS Growth in Last Year: 27.50 %

Sales Growth in Last Quarter: 0.68 %

Sales Growth in Last Quarter: 16.37 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 2.190